FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/05/087834 [Registered on: 28/05/2025] Trial Registered Prospectively
Last Modified On: 28/05/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparative study on efficacy of Erandadi kwatha and symhasyadi kwatha in treatment of Gridhrasi (sciatica) 
Scientific Title of Study   A comparative clinical study to evaluate the efficacy of Erandadi kwatha and symhasyadi kwatha in the management of Gridhrasi with special reference to sciatica.  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Vaishnavi kiranrao Sowale  
Designation  MD scholar 
Affiliation  Department of kayachikitsa Shree Saptashrungi Ayurved Mahavidyala And Hospital Nashik 
Address  OPD NO.2 Department of Kayachikitsa, Shree Saptashrungi Ayurved Mahavidyala and Hospital,Kamal Nagar, Hirawadi, Panchawati,Nashik Maharashtra422003

Nashik
MAHARASHTRA
422003
India 
Phone  8999349832  
Fax    
Email  Vaishnavi.sowale@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Somdatta Bhaskarrao Kulkarni  
Designation  HOD 
Affiliation  Department of kayachikitsa, Shree Saptashrungi Ayurved Mahavidyala, and Hospital Nashik  
Address  OPD No. 2 Department of kayachikitsa, Shree Saptashrungi Ayurved Mahavidyala and Hospital, Kamal Nagar, Hirawadi Panchawati Nashik 422003

Nashik
MAHARASHTRA
422003
India 
Phone  8999349832  
Fax    
Email  Somdattak85@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DrVaishnavi kiranrao Sowale  
Designation  MD scholar  
Affiliation  Department of kayachikitsa Shree Saptashrungi Ayurved Mahavidyala and Hospital Nashik  
Address  OPD NO.2 Department of kayachikitsa, Shree Saptashrungi Ayurved Mahavidyala and Hospital Kamal Nagar Hirawadi Panchawati Nashik Maharashtra 422003

Nashik
MAHARASHTRA
422003
India 
Phone  8999349832  
Fax    
Email  vaishnavi.sowale@gmail.com  
 
Source of Monetary or Material Support  
Department of kayachikitsa Shree Saptashrungi Ayurved Mahavidyala and Hospital Kamal Nagar Hirawadi Panchawati Nashik Maharashtra 422003 
 
Primary Sponsor  
Name  Shree saptashrungi Ayurved Mahavidyala and Hospital Kamal Nagar Hirawadi Panchawati Nashik  
Address  Department of kayachikitsa Shree Saptashrungi Ayurved Mahavidyala and Hospital Kamal Nagar Hirawadi Panchawati Nashik Maharashtra 422003 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Vaishnavi kiranrao Sowale   Shree saptashrungi Ayurved Mahavidyala and Hospital   Department of kayachikitsa Shree Saptashrungi Ayurved Mahavidyala and Hospital Kamal Nagar Hirawadi Panchawati Nashik Maharashtra 422003
Nashik
MAHARASHTRA 
8999349832

Vaishnavi.sowale@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC Shree saptashrungi Ayurved Mahavidyala and Hospital Nashik  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:G55||Nerve root and plexus compressionsin diseases classified elsewhere. Ayurveda Condition: GRUDHRASI,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Erandadi kwatha , Reference: Bhaishajya ratnavali 26 , Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 48(ml), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: -saindhav ), Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Symhasyadi kwatha , Reference: Bhaishajya ratnavali 26 , Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 48(ml), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: Erand sneha), Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Patient having positive straight leg raise test. 
 
ExclusionCriteria 
Details  1) patient having lower limb paraplegia or hemiplegia.
2) pregnant and lactating women.
3) History of any vertibral/surgical/diagnostic intervention with reference to affected joints
4) gross disability in performing daily normal routine that is bedridden patient or confined to wheelchair
5) patient with known comorbidities such as gouty arthritis, rheumatoid arthritis or psoriatic arthritis, tubercular arthritis
6) patient with evidence of malignancy  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Reduction in signs and symptoms of gridhrasi  At base line 15th and 30th day 
 
Secondary Outcome  
Outcome  TimePoints 
Reduction in sign & symptoms of Gridhrasi with improvement in SLR test Grading  30th Day 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   09/06/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Primary objectives - 1) To study the effect of Erandadi kwatha in Gridhrasi 
                                      2) To study the effect of Simhasyadi Kwatha in Gridhrasi.
                                       3) To compare the effect of Erandadi kwatha with Simhasyadi Kwatha in management of Gridhrasi with special reference to sciatica 
Study -  Comparative clinical study.
Group A - Erandadi kwatha 
Group B - Simhasyadi Kwatha 

Duration of treatment - 30 Days 
Initial assessment on 1st day
Follow up on 15th and 30th day

Data Analysis - Data will be analysed  using appropriate statistical methods to compare the effectiveness of intervention on primary and secondary outcomes.

Ethical considerations - The study will be conducted in accordance with Ethical Guidelines and with infirmed consent from participants.
Conclusion - conclusion will be drawn on the basis of statistical analysis of data.
 
Close